(2R,3R,4R,5R)-2,5-bis[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoxy]-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-6-oxo-6-[2-(3-phenylpropanoyl)hydrazinyl]hexanamide

InChIKey	`LBUNQXVGLNKGEB-HWROJPHKSA-N`
Compound Name	(2R,3R,4R,5R)-2,5-bis[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoxy]-3,4-dihydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-6-oxo-6-[2-(3-phenylpropanoyl)hydrazinyl]hexanamide
Canonical SMILES	`O=C(CCc1ccccc1)NNC(=O)[C@H](OC/C=C/c1ccc2c(c1)OCO2)[C@H](O)[C@@H](O)[C@@H](OC/C=C/c1ccc2c(c1)OCO2)C(=O)N[C@H]1c2ccccc2C[C@H]1O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	7.43
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P07339	CTSD	Homo sapiens	Human	PF07966 PF00026	6.1	Ki	ChEMBL;BindingDB
P39898	PMI	Plasmodium falciparum (isolate HB3)	Pathogen	PF00026	8.2	Ki	ChEMBL;BindingDB
P46925	PMII	Plasmodium falciparum (isolate HB3)	Pathogen	PF00026	8.0	Ki	ChEMBL;BindingDB